Literature DB >> 23261605

Morphobase, an encyclopedic cell morphology database, and its use for drug target identification.

Yushi Futamura1, Makoto Kawatani, Sayaka Kazami, Kenichi Tanaka, Makoto Muroi, Takeshi Shimizu, Koji Tomita, Nobumoto Watanabe, Hiroyuki Osada.   

Abstract

Visual observation is a powerful approach for screening bioactive compounds that can facilitate the discovery of attractive druggable targets following their chemicobiological validation. So far, many high-content approaches, using sophisticated imaging technology and bioinformatics, have been developed. In our study, we aimed to develop a simpler method that focuses on intact cell images because we found that dynamic changes in morphology are informative, often reflecting the mechanism of action of a drug. Here, we constructed a chemical-genetic phenotype profiling system, based on the high-content cell morphology database Morphobase. This database compiles the phenotypes of cancer cell lines that are induced by hundreds of reference compounds, wherein those of well-characterized anticancer drugs are classified by mode of action. Furthermore, we demonstrate the applicability of this system in identifying NPD6689, NPD8617, and NPD8969 as tubulin inhibitors.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23261605     DOI: 10.1016/j.chembiol.2012.10.014

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  23 in total

Review 1.  Biological targets and mechanisms of action of natural products from marine cyanobacteria.

Authors:  Lilibeth A Salvador-Reyes; Hendrik Luesch
Journal:  Nat Prod Rep       Date:  2015-03       Impact factor: 13.423

Review 2.  Applications of chemogenomic library screening in drug discovery.

Authors:  Lyn H Jones; Mark E Bunnage
Journal:  Nat Rev Drug Discov       Date:  2017-01-20       Impact factor: 84.694

3.  Identifying the macromolecular targets of de novo-designed chemical entities through self-organizing map consensus.

Authors:  Daniel Reker; Tiago Rodrigues; Petra Schneider; Gisbert Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-03       Impact factor: 11.205

Review 4.  Chemical and biological studies of reveromycin A.

Authors:  Hiroyuki Osada
Journal:  J Antibiot (Tokyo)       Date:  2016-06-08       Impact factor: 2.649

5.  Ordering Single Cells and Single Embryos in 3D Confinement: A New Device for High Content Screening.

Authors:  Viktoria Wollrab; David Caballero; Raghavan Thiagarajan; Daniel Riveline
Journal:  J Vis Exp       Date:  2016-09-18       Impact factor: 1.355

Review 6.  Integrating phenotypic small-molecule profiling and human genetics: the next phase in drug discovery.

Authors:  Cory M Johannessen; Paul A Clemons; Bridget K Wagner
Journal:  Trends Genet       Date:  2014-12-12       Impact factor: 11.639

7.  Cell Painting, a high-content image-based assay for morphological profiling using multiplexed fluorescent dyes.

Authors:  Mark-Anthony Bray; Shantanu Singh; Han Han; Chadwick T Davis; Blake Borgeson; Cathy Hartland; Maria Kost-Alimova; Sigrun M Gustafsdottir; Christopher C Gibson; Anne E Carpenter
Journal:  Nat Protoc       Date:  2016-08-25       Impact factor: 13.491

8.  Phenotypic profiling of antibiotic response signatures in Escherichia coli using Raman spectroscopy.

Authors:  A I M Athamneh; R A Alajlouni; R S Wallace; M N Seleem; R S Senger
Journal:  Antimicrob Agents Chemother       Date:  2013-12-02       Impact factor: 5.191

Review 9.  Proteomics-based target identification of natural products affecting cancer metabolism.

Authors:  Makoto Muroi; Hiroyuki Osada
Journal:  J Antibiot (Tokyo)       Date:  2021-07-20       Impact factor: 2.649

10.  Morphological Profiles of RNAi-Induced Gene Knockdown Are Highly Reproducible but Dominated by Seed Effects.

Authors:  Shantanu Singh; Xiaoyun Wu; Vebjorn Ljosa; Mark-Anthony Bray; Federica Piccioni; David E Root; John G Doench; Jesse S Boehm; Anne E Carpenter
Journal:  PLoS One       Date:  2015-07-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.